Lv51
1128 积分 2021-12-07 加入
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
1小时前
已完结
Is antibiotic prophylaxis necessary for anterior epistaxis with packing? Insights from a large database
1天前
已完结
[Chinese experts consensus on the diagnosis and management of checkpoint inhibitor pneumonitis(2025)]
1个月前
已完结
Real-world evaluation of imipenem/cilastatin/relebactam across US medical centres
2个月前
已完结
The epidemiological and molecular characteristics and sulbactam-durlobactam susceptibility of carbapenem-resistant Acinetobacter baumannii in a Chinese teaching hospital
6个月前
已完结
The role of sulbactam-durlobactam in treating carbapenem-resistant Acinetobacter infections
6个月前
已完结
Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
6个月前
已完结
Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID‐19
7个月前
已完结
Plasma Concentration of Posaconazole in Septic Shock Patients with Continuous Renal Replacement Therapy: A Case Report
8个月前
已关闭
皖公网安备34019202002308
